A Clinical Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris

Completed · Phase 2 · Has a placebo group

Conditions studied: Acne Vulgaris

In brief

The purpose of this study is to assess the safety and effectiveness of IDP-107 in treating patients with acne vulgaris.

Key facts

Study ID
NCT00666900
Run by
Dow Pharmaceutical Sciences
People needed
366
Starts
2008-01-01
Expected to finish
2009-09-01
Last updated by the study team
2012-02-20

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.